Clinical Trial Update: Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating talimogene laherparepvec with cisplatin and radiotherapy for locally advanced head and neck cancer was terminated, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Talimogene laherparepvec (talimogene laherparepvec)

Snippet

Sponsor: BioVex Limited | Conditions: Squamous Cell Carcinoma, Head and Neck Cancer | Phase 3 | Status: TERMINATED | Results posted: 2015-12-17